What are the treatment options for female hair loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Female Hair Loss

For female pattern hair loss (FPHL), topical 5% minoxidil foam applied once daily is the first-line treatment, which should be continued for at least 12 months to properly evaluate response, with maintenance therapy required indefinitely to sustain results. 1

Types of Female Hair Loss

There are two main types of hair loss affecting women:

  1. Female Pattern Hair Loss (FPHL) - Most common type

    • Progressive thinning of hair, especially in frontal, central, and parietal scalp
    • May or may not have elevated androgen levels
    • Characterized by follicular miniaturization
  2. Alopecia Areata - Patchy hair loss

    • Limited patches: Often resolves spontaneously
    • Extensive/total/universal: More difficult to treat

Treatment Algorithm for FPHL

First-line Treatment:

  • Topical 5% minoxidil foam once daily 1
    • Continue for minimum 6 months before evaluating initial response
    • Full evaluation at 12 months
    • Must be continued indefinitely to maintain results

Second-line/Alternative Options:

  • Low-dose oral combination therapy 1

    • Minoxidil 0.25 mg + spironolactone 25 mg once daily
    • Particularly useful for women with signs of androgen excess
  • Platelet-rich plasma (PRP) therapy 1

    • Initial phase: 3 sessions at 4-6 week intervals
    • Maintenance: Sessions every 6 months
    • Can be used alone or as adjunct to minoxidil
  • Low-level laser therapy 1

    • Used 3 times weekly
    • Minimal side effects
    • Can increase total hair count
  • Spironolactone (25-200 mg daily) 1, 2

    • Particularly effective when FPHL is associated with hyperandrogenism
    • Acts as an androgen receptor antagonist

For Severe or Treatment-Resistant Cases:

  • Finasteride (1-2.5 mg daily) 1, 2

    • May be effective in postmenopausal women
    • Contraindicated in women of childbearing potential due to teratogenicity
    • Warning: Pregnant women should not handle tablets
  • Hair transplantation 1

    • For advanced FPHL resistant to medical treatments
    • Requires well-preserved donor hair at the occipital region

Treatment for Alopecia Areata

Limited Patchy Hair Loss:

  • Intralesional corticosteroids 3, 1
    • Triamcinolone acetonide (5-10 mg/mL)
    • Best for fewer than five patches of <3 cm diameter

Extensive Alopecia Areata:

  • Contact immunotherapy 3, 1
    • Diphenylcyclopropenone (DPCP)
    • 50-60% of patients achieve worthwhile response
    • Requires multiple hospital visits over several months
    • Store solutions in the dark; patients should wear hat/wig for 24h after application

Monitoring Treatment Response

  • 3-month mark: Early signs of improvement may be visible
  • 6-month mark: Critical evaluation point; significant improvements should be noticeable
  • 12-month mark: Comprehensive evaluation of treatment efficacy
  • Evaluation methods: Standardized clinical photography, trichoscopy, hair counts, patient self-assessment 1

Important Considerations and Pitfalls

  • Don't discontinue treatment prematurely - Results take 6-12 months to become apparent 1
  • Rule out underlying conditions - Check thyroid function, iron stores, vitamin D levels 1
  • Set realistic expectations - Treatments are better at preventing progression than stimulating regrowth 4
  • Consider psychological impact - Hair loss can cause significant psychological distress in women 4, 5
  • For cosmetic improvement - Wigs, hairpieces, and cosmetic camouflage can be helpful while awaiting treatment response 3, 1

Treatment Efficacy Evidence

  • Minoxidil shows moderate to marked increase in hair regrowth compared to placebo, with an important increase in total hair count 6
  • Low-level laser therapy shows improvement in total hair count compared to sham devices 6
  • Finasteride 1mg has shown limited efficacy in premenopausal women but may be effective at higher doses (2.5mg) in postmenopausal women 2, 6
  • All treatments need to be continued to maintain effect, as FPHL is a chronic progressive condition 4

References

Guideline

Female Pattern Hair Loss Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hair loss in women.

Seminars in cutaneous medicine and surgery, 2009

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Female pattern hair loss: current treatment concepts.

Clinical interventions in aging, 2007

Research

Interventions for female pattern hair loss.

The Cochrane database of systematic reviews, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.